Hartz S - Search Results

1

Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain.

Schweikert B, Malmberg C, Núñez M, Dilla T, Sapin C, Hartz S. Schweikert B, et al. Among authors: hartz s. BMJ Open. 2020 Aug 13;10(8):e032552. doi: 10.1136/bmjopen-2019-032552. BMJ Open. 2020. PMID: 32792421 Free PMC article.

2

Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study.

Reich K, Pinter A, Lacour JP, Ferrandiz C, Micali G, French LE, Lomaga M, Dutronc Y, Henneges C, Wilhelm S, Hartz S, Paul C; IXORA-S investigators. Reich K, et al. Among authors: hartz s. Br J Dermatol. 2017 Oct;177(4):1014-1023. doi: 10.1111/bjd.15666. Epub 2017 Jul 19. Br J Dermatol. 2017. PMID: 28542874 Clinical Trial.

3

Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis.

Al Sawah S, Foster SA, Burge R, Amato D, Schacht A, Zhu B, Hartz S, Leonardi C. Al Sawah S, et al. Among authors: hartz s. J Med Econ. 2017 Dec;20(12):1224-1230. doi: 10.1080/13696998.2017.1362413. Epub 2017 Aug 22. J Med Econ. 2017. PMID: 28760056 Free article.

4

Cost-effectiveness analysis of sequential biologic therapy with ixekizumab versus secukinumab as first-line treatment of moderate-to-severe psoriasis in the UK.

Johansson EC, Hartz S, Kiri SH, Kumar G, Svedbom A. Johansson EC, et al. Among authors: hartz s. J Med Econ. 2018 Aug;21(8):810-820. doi: 10.1080/13696998.2018.1474747. Epub 2018 Jun 6. J Med Econ. 2018. PMID: 29873270 Free article.

5

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain.

Johansson E, Nuñez M, Svedbom A, Dilla T, Hartz S. Johansson E, et al. Among authors: hartz s. Clinicoecon Outcomes Res. 2018 Nov 12;10:747-759. doi: 10.2147/CEOR.S167727. eCollection 2018. Clinicoecon Outcomes Res. 2018. PMID: 30519064 Free PMC article.

6

A Cost-per-Number Needed to Treat Analysis Assessing the Efficiency of Biologic Drugs in Moderate to Severe Plaque Psoriasis.

Núñez M, Huete T, de la Cueva P, Sacristán JA, Hartz S, Dilla T. Núñez M, et al. Among authors: hartz s. Actas Dermosifiliogr (Engl Ed). 2019 Sep;110(7):546-553. doi: 10.1016/j.ad.2018.10.017. Epub 2019 Mar 7. Actas Dermosifiliogr (Engl Ed). 2019. PMID: 30851873 English, Spanish.

7

Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis.

Ruyssen-Witrand A, Perry R, Watkins C, Braileanu G, Kumar G, Kiri S, Nott D, Liu-Leage S, Hartz S, Sapin C. Ruyssen-Witrand A, et al. Among authors: hartz s. RMD Open. 2020 Feb;6(1):e001117. doi: 10.1136/rmdopen-2019-001117. RMD Open. 2020. PMID: 32094304 Free PMC article.

8

Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK.

Schweikert B, Malmberg C, Åkerborg Ö, Kumar G, Nott D, Kiri S, Sapin C, Hartz S. Schweikert B, et al. Among authors: hartz s. Pharmacoecon Open. 2020 Dec;4(4):635-648. doi: 10.1007/s41669-020-00202-1. Pharmacoecon Open. 2020. PMID: 32166657 Free PMC article.

9

Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis.

Dignass A, Ainsworth C, Hartz S, Dunnewind N, Redondo I, Sapin C, Kroep S, Halfpenny N, Arcà E, Hoque S. Dignass A, et al. Among authors: hartz s. Adv Ther. 2024 Dec;41(12):4446-4462. doi: 10.1007/s12325-024-03003-8. Epub 2024 Oct 15. Adv Ther. 2024. PMID: 39404996 Free PMC article.

10

Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method.

Mrowietz U, Warren RB, Leonardi CL, Saure D, Petto H, Hartz S, Dossenbach M, Reich K. Mrowietz U, et al. Among authors: hartz s. J Eur Acad Dermatol Venereol. 2021 May;35(5):1161-1175. doi: 10.1111/jdv.17130. Epub 2021 Feb 15. J Eur Acad Dermatol Venereol. 2021. PMID: 33480102 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters